ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,000 | -75.0% | 55,075 | 0.0% | 0.00% | – |
Q2 2023 | $28,000 | +12.0% | 55,075 | +37.4% | 0.00% | – |
Q1 2023 | $25,000 | 0.0% | 40,074 | 0.0% | 0.00% | – |
Q4 2022 | $25,000 | -63.8% | 40,074 | -0.5% | 0.00% | – |
Q3 2022 | $69,000 | +25.5% | 40,275 | -19.9% | 0.00% | – |
Q2 2022 | $55,000 | +103.7% | 50,275 | +17.5% | 0.00% | – |
Q1 2022 | $27,000 | -41.3% | 42,775 | 0.0% | 0.00% | – |
Q4 2021 | $46,000 | -51.6% | 42,775 | -17.5% | 0.00% | – |
Q3 2021 | $95,000 | -30.1% | 51,875 | +0.7% | 0.00% | – |
Q2 2021 | $136,000 | -36.2% | 51,491 | -12.7% | 0.00% | -100.0% |
Q1 2021 | $213,000 | +70.4% | 58,991 | +18.2% | 0.00% | 0.0% |
Q3 2020 | $125,000 | -61.9% | 49,891 | -49.9% | 0.00% | -50.0% |
Q2 2020 | $328,000 | +1.9% | 99,666 | -24.1% | 0.00% | 0.0% |
Q1 2020 | $322,000 | -49.4% | 131,274 | -2.8% | 0.00% | -50.0% |
Q4 2019 | $636,000 | -1.9% | 135,074 | -10.8% | 0.00% | 0.0% |
Q3 2019 | $648,000 | -21.6% | 151,501 | +6.6% | 0.00% | -20.0% |
Q2 2019 | $827,000 | +39.0% | 142,176 | -8.3% | 0.01% | +25.0% |
Q1 2019 | $595,000 | +200.5% | 154,976 | +45.4% | 0.00% | +100.0% |
Q4 2018 | $198,000 | -41.2% | 106,580 | +0.9% | 0.00% | 0.0% |
Q3 2018 | $337,000 | +9.8% | 105,676 | +2.7% | 0.00% | 0.0% |
Q2 2018 | $307,000 | -28.1% | 102,876 | -5.2% | 0.00% | -50.0% |
Q1 2018 | $427,000 | +31.0% | 108,576 | +37.5% | 0.00% | +33.3% |
Q4 2017 | $326,000 | +15.6% | 78,976 | +71.2% | 0.00% | +50.0% |
Q3 2017 | $282,000 | -6.0% | 46,122 | -4.5% | 0.00% | -33.3% |
Q2 2017 | $300,000 | -22.7% | 48,310 | -21.1% | 0.00% | -25.0% |
Q1 2017 | $388,000 | +17.9% | 61,194 | -0.8% | 0.00% | 0.0% |
Q4 2016 | $329,000 | -8.9% | 61,694 | -3.4% | 0.00% | 0.0% |
Q3 2016 | $361,000 | +86.1% | 63,864 | +80.1% | 0.00% | +100.0% |
Q2 2016 | $194,000 | -31.0% | 35,454 | -6.6% | 0.00% | +100.0% |
Q1 2016 | $281,000 | -3.1% | 37,954 | +7.4% | 0.00% | -66.7% |
Q4 2015 | $290,000 | -37.6% | 35,349 | -32.0% | 0.00% | -50.0% |
Q3 2015 | $465,000 | +9.2% | 51,981 | +46.6% | 0.01% | -14.3% |
Q2 2015 | $426,000 | +20.0% | 35,465 | +7.7% | 0.01% | +40.0% |
Q1 2015 | $355,000 | +277.7% | 32,935 | +78.0% | 0.01% | +400.0% |
Q4 2014 | $94,000 | +91.8% | 18,500 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $49,000 | -23.4% | 18,500 | +15.6% | 0.00% | 0.0% |
Q2 2014 | $64,000 | -13.5% | 16,000 | -59.8% | 0.00% | 0.0% |
Q1 2014 | $74,000 | -6.3% | 39,800 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $79,000 | +25.4% | 39,800 | +148.8% | 0.00% | -50.0% |
Q3 2013 | $63,000 | +50.0% | 16,000 | -65.2% | 0.00% | +100.0% |
Q2 2013 | $42,000 | – | 46,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |